| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.817 | 0.009 | 0.817 | Caspase 9 stimulant | |||
| 0.788 | 0.018 | 0.788 | Apoptosis agonist | 0.425 0.102 CID_101164969 | ||
| 0.765 | 0.005 | 0.765 | Caspase 3 stimulant | |||
| 0.606 | 0.007 | 0.606 | GABA C receptor rho-3 antagonist | |||
| 0.536 | 0.004 | 0.536 | Aldehyde dehydrogenase inhibitor | 0.273 0.015 CID_101164969 | ||
| 0.537 | 0.022 | 0.537 | 5 Hydroxytryptamine release stimulant | |||
| 0.496 | 0.003 | 0.496 | TRPA1 agonist | |||
| 0.483 | 0.023 | 0.483 | Apoptosis antagonist | 0.323 0.071 CID_101164969 | ||
| 0.428 | 0.004 | 0.428 | Sigma 1 receptor antagonist | |||
| 0.418 | 0.003 | 0.418 | CYP2A6 inhibitor | |||
| 0.388 | 0.004 | 0.388 | TRPA1 antagonist | |||
| 0.381 | 0.004 | 0.381 | Macrophage migration inhibitory factor inhibitor | |||
| 0.365 | 0.022 | 0.365 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.366 | 0.03 | 0.366 | Nitric oxide antagonist | |||
| 0.315 | 0.005 | 0.315 | Sigma receptor antagonist | |||
| 0.317 | 0.026 | 0.317 | Tyrosine 3 hydroxylase inhibitor | 0.215 0.111 CID_101164969 | ||
| 0.292 | 0.002 | 0.292 | Vanilloid 2 antagonist | 0.062 0.021 CID_101164969 | ||
| 0.287 | 0.006 | 0.287 | GABA C receptor rho-2 antagonist | |||
| 0.275 | 0.003 | 0.275 | Adenylate cyclase stimulant | 0.157 0.051 CID_101164969 | ||
| 0.377 | 0.122 | 0.377 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.316 | 0.064 | 0.316 | Spasmolytic | |||
| 0.261 | 0.012 | 0.261 | GABA C receptor agonist | |||
| 0.257 | 0.011 | 0.257 | Antibacterial (Helicobacter pylori) | 0.107 0.105 CID_101164969 | ||
| 0.248 | 0.006 | 0.248 | GABA C receptor antagonist | |||
| 0.248 | 0.017 | 0.248 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.297 | 0.067 | 0.297 | Aldehyde oxidase inhibitor | |||
| 0.272 | 0.043 | 0.723 | Peroxidase inhibitor | 0.723 0.003 CID_101164969 | CID_101164969 | |
| 0.292 | 0.063 | 0.431 | Insulysin inhibitor | 0.431 0.017 CID_101164969 | CID_101164969 | |
| 0.305 | 0.077 | 0.666 | Immunostimulant | 0.666 0.01 CID_101164969 | CID_101164969 | |
| 0.23 | 0.005 | 0.23 | GABA C receptor rho-1 antagonist | |||
| 0.253 | 0.03 | 0.253 | Nitric-oxide synthase stimulant | |||
| 0.27 | 0.063 | 0.409 | Superoxide dismutase inhibitor | 0.409 0.025 CID_101164969 | CID_101164969 | |
| 0.255 | 0.048 | 0.255 | Anesthetic general | |||
| 0.333 | 0.13 | 0.333 | 5 Hydroxytryptamine release inhibitor | |||
| 0.211 | 0.01 | 0.211 | Hedgehog signaling inhibitor | |||
| 0.291 | 0.101 | 0.291 | Calcium channel activator | |||
| 0.187 | 0.012 | 0.187 | Opioid kappa receptor antagonist | |||
| 0.182 | 0.01 | 0.182 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 CID_101164969 | ||
| 0.174 | 0.003 | 0.174 | Exportin-1 inhibitor | |||
| 0.194 | 0.024 | 0.194 | Ferrochelatase inhibitor | |||
| 0.201 | 0.034 | 0.201 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.174 | 0.009 | 0.3 | Phenylalanine 4-hydroxylase inhibitor | 0.3 0.004 CID_101164969 | CID_101164969 | |
| 0.176 | 0.015 | 0.176 | Nitric-oxide synthase inhibitor | 0.156 0.02 CID_101164969 | ||
| 0.166 | 0.007 | 0.166 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.242 | 0.088 | 0.285 | Antioxidant | 0.285 0.068 CID_101164969 | CID_101164969 | |
| 0.165 | 0.012 | 0.165 | Cannabinoid receptor antagonist | |||
| 0.264 | 0.118 | 0.291 | Transcription factor NF kappa B inhibitor | 0.291 0.1 CID_101164969 | CID_101164969 | |
| 0.236 | 0.09 | 0.236 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.16 | 0.018 | 0.16 | Porphobilinogen synthase inhibitor | |||
| 0.158 | 0.018 | 0.158 | Opioid delta receptor antagonist | |||
| 0.244 | 0.113 | 0.244 | 12-Lipoxygenase inhibitor | |||
| 0.137 | 0.009 | 0.137 | Cannabinoid CB1 receptor antagonist | |||
| 0.152 | 0.025 | 0.152 | Opioid antagonist | 0.077 0.073 CID_101164969 | ||
| 0.23 | 0.105 | 0.246 | Gastrin inhibitor | 0.246 0.084 CID_101164969 | CID_101164969 | |
| 0.141 | 0.017 | 0.141 | Histamine N-methyltransferase inhibitor | |||
| 0.192 | 0.078 | 0.192 | Non-steroidal antiinflammatory agent | |||
| 0.214 | 0.101 | 0.267 | Calpain inhibitor | 0.267 0.051 CID_101164969 | CID_101164969 | |
| 0.134 | 0.021 | 0.134 | Opioid mu receptor antagonist | |||
| 0.284 | 0.171 | 0.284 | Calcium channel L-type activator | |||
| 0.256 | 0.146 | 0.256 | Calpain 2 inhibitor | 0.25 0.149 CID_101164969 | ||
| 0.148 | 0.039 | 0.411 | Aminopeptidase B inhibitor | 0.411 0.004 CID_101164969 | CID_101164969 | |
| 0.136 | 0.028 | 0.136 | Acetylcholine release stimulant | |||
| 0.127 | 0.019 | 0.572 | Glutamate decarboxylase inhibitor | 0.572 0.002 CID_101164969 | CID_101164969 | |
| 0.151 | 0.044 | 0.151 | Adenylate cyclase inhibitor | |||
| 0.114 | 0.013 | 0.114 | Estrogen-related receptor beta agonist | |||
| 0.141 | 0.041 | 0.141 | 5 Hydroxytryptamine 3A agonist | |||
| 0.157 | 0.059 | 0.157 | Cell wall synthesis inhibitor | 0.146 0.07 CID_101164969 | ||
| 0.147 | 0.05 | 0.147 | Ca2+-transporting ATPase inhibitor | |||
| 0.108 | 0.013 | 0.108 | Cannabinoid CB2 receptor antagonist | |||
| 0.106 | 0.017 | 0.106 | Dopamine uptake inhibitor | |||
| 0.168 | 0.082 | 0.168 | Succinate dehydrogenase inhibitor | |||
| 0.133 | 0.047 | 0.133 | MAO A inhibitor | |||
| 0.191 | 0.105 | 0.197 | Free radical scavenger | 0.197 0.1 CID_101164969 | CID_101164969 | |
| 0.09 | 0.005 | 0.09 | Sigma 2 receptor antagonist | |||
| 0.161 | 0.076 | 0.161 | Arachidonic acid antagonist | |||
| 0.124 | 0.041 | 0.124 | DOPA decarboxylase inhibitor | |||
| 0.084 | 0.004 | 0.084 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.105 | 0.025 | 0.212 | Aminopeptidase I inhibitor | 0.212 0.006 CID_101164969 | CID_101164969 | |
| 0.115 | 0.035 | 0.115 | Triose-phosphate isomerase inhibitor | |||
| 0.118 | 0.039 | 0.118 | Prolactin inhibitor | |||
| 0.094 | 0.018 | 0.094 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.198 | 0.123 | 0.245 | Interleukin agonist | 0.245 0.082 CID_101164969 | CID_101164969 | |
| 0.104 | 0.03 | 0.104 | NMDA 2 receptor antagonist | |||
| 0.079 | 0.005 | 0.079 | Benzodiazepine antagonist | |||
| 0.174 | 0.102 | 0.174 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.088 | 0.017 | 0.088 | Glutamate (mGluR6) antagonist | |||
| 0.106 | 0.038 | 0.106 | NADH dehydrogenase inhibitor | |||
| 0.114 | 0.046 | 0.114 | Sphingomyelinase inhibitor | |||
| 0.102 | 0.033 | 0.102 | Myeloperoxidase inhibitor | |||
| 0.097 | 0.028 | 0.097 | Carbonic anhydrase inhibitor | 0.084 0.033 CID_101164969 | ||
| 0.075 | 0.007 | 0.075 | Dopamine D5 agonist | |||
| 0.116 | 0.049 | 0.116 | Urease inhibitor | |||
| 0.114 | 0.049 | 0.114 | Adenylate kinase inhibitor | 0.11 0.053 CID_101164969 | ||
| 0.224 | 0.16 | 0.224 | Vasodilator, coronary | |||
| 0.073 | 0.009 | 0.073 | Immunoglobulin Fc receptor antagonist | |||
| 0.154 | 0.092 | 0.222 | Neurotensin receptor agonist | 0.222 0.027 CID_101164969 | CID_101164969 | |
| 0.111 | 0.05 | 0.111 | UDP-glucose 4-epimerase inhibitor | |||
| 0.071 | 0.01 | 0.071 | Histamine H2 receptor agonist | |||
| 0.129 | 0.069 | 0.169 | Vanilloid 1 agonist | 0.169 0.024 CID_101164969 | CID_101164969 | |
| 0.247 | 0.188 | 0.247 | Transcription factor inhibitor | |||
| 0.192 | 0.134 | 0.192 | Neuropeptide Y2 antagonist | 0.181 0.157 CID_101164969 | ||
| 0.128 | 0.069 | 0.151 | Cyclooxygenase 3 inhibitor | 0.151 0.048 CID_101164969 | CID_101164969 | |
| 0.168 | 0.112 | 0.168 | Neurotrophic factor enhancer | |||
| 0.08 | 0.024 | 0.08 | Alcohol oxidase inhibitor | |||
| 0.107 | 0.052 | 0.107 | Creatine kinase inhibitor | |||
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase VA inhibitor | |||
| 0.107 | 0.055 | 0.107 | Carbonic anhydrase III inhibitor | |||
| 0.063 | 0.012 | 0.063 | Dopamine beta hydroxylase inhibitor | |||
| 0.058 | 0.009 | 0.058 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.078 | 0.029 | 0.078 | Cannabinoid CB1 receptor agonist | |||
| 0.067 | 0.02 | 0.067 | Epithelial sodium channel blocker | |||
| 0.065 | 0.017 | 0.065 | Carbonic anhydrase IV inhibitor | 0.058 0.02 CID_101164969 | ||
| 0.086 | 0.039 | 0.086 | GABA aminotransferase inhibitor | |||
| 0.121 | 0.074 | 0.121 | Cathepsin H inhibitor | |||
| 0.106 | 0.06 | 0.106 | Carbonic anhydrase XV inhibitor | |||
| 0.141 | 0.095 | 0.141 | Melanin inhibitor | |||
| 0.08 | 0.035 | 0.08 | Carbonic anhydrase V inhibitor | |||
| 0.065 | 0.022 | 0.065 | Aconitate hydratase inhibitor | |||
| 0.098 | 0.056 | 0.13 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.13 0.034 CID_101164969 | CID_101164969 | |
| 0.071 | 0.029 | 0.071 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.051 | 0.01 | 0.051 | Purinergic P2Y2 antagonist | |||
| 0.135 | 0.094 | 0.135 | Heat shock protein 70 antagonist | |||
| 0.122 | 0.081 | 0.122 | Nav1.2 sodium channel blocker | |||
| 0.103 | 0.063 | 0.103 | Alpha 2c adrenoreceptor antagonist | |||
| 0.117 | 0.078 | 0.117 | DNA repair enzyme inhibitor | |||
| 0.053 | 0.014 | 0.053 | Histamine H1 receptor agonist | |||
| 0.067 | 0.028 | 0.067 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.124 | 0.086 | 0.124 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.101 | 0.063 | 0.101 | Bronchodilator | |||
| 0.069 | 0.033 | 0.069 | Biliverdin reductase inhibitor | |||
| 0.089 | 0.053 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.103 | 0.067 | 0.103 | Falcipain 3 inhibitor | |||
| 0.065 | 0.029 | 0.065 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.068 | 0.032 | 0.068 | Calcium channel P-type blocker | |||
| 0.056 | 0.021 | 0.056 | Adenylate cyclase 1 inhibitor | |||
| 0.176 | 0.141 | 0.176 | RNA-directed DNA polymerase inhibitor | |||
| 0.065 | 0.032 | 0.091 | Carbonic anhydrase I inhibitor | 0.091 0.021 CID_101164969 | CID_101164969 | |
| 0.088 | 0.056 | 0.088 | NMDA receptor antagonist | |||
| 0.083 | 0.052 | 0.083 | Glycine receptor antagonist | |||
| 0.146 | 0.115 | 0.535 | Phospholipase C inhibitor | 0.535 0.005 CID_101164969 | CID_101164969 | |
| 0.063 | 0.033 | 0.072 | Carbonic anhydrase II inhibitor | 0.072 0.029 CID_101164969 | CID_101164969 | |
| 0.065 | 0.035 | 0.125 | Carbonic anhydrase stimulant | 0.125 0.014 CID_101164969 | CID_101164969 | |
| 0.048 | 0.02 | 0.048 | Thymidine kinase inhibitor | |||
| 0.063 | 0.037 | 0.063 | Beta 2 adrenoreceptor agonist | |||
| 0.045 | 0.018 | 0.045 | Diamine oxidase inhibitor | |||
| 0.091 | 0.065 | 0.091 | MAO B inhibitor | |||
| 0.105 | 0.079 | 0.105 | Photosensitizer | |||
| 0.095 | 0.069 | 0.095 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.057 | 0.031 | 0.067 | NMDA 2A receptor antagonist | 0.067 0.026 CID_101164969 | CID_101164969 | |
| 0.046 | 0.021 | 0.046 | Heme oxygenase inhibitor | |||
| 0.039 | 0.015 | 0.039 | Melatonin receptor 1A agonist | |||
| 0.071 | 0.047 | 0.071 | Phosphofructokinase-1 inhibitor | |||
| 0.1 | 0.076 | 0.1 | Cystathionine beta-synthase inhibitor | |||
| 0.064 | 0.04 | 0.064 | NMDA 2C receptor antagonist | |||
| 0.057 | 0.034 | 0.057 | GABA receptor antagonist | |||
| 0.063 | 0.04 | 0.063 | Purinergic P2X1 antagonist | |||
| 0.074 | 0.051 | 0.15 | Glutamate dehydrogenase inhibitor | 0.15 0.016 CID_101164969 | CID_101164969 | |
| 0.081 | 0.06 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.055 | 0.034 | 0.055 | GABA A receptor antagonist | |||
| 0.038 | 0.019 | 0.038 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.046 | 0.026 | 0.046 | Glutamate (mGluR group III) antagonist | |||
| 0.042 | 0.024 | 0.065 | Membrane dipeptidase inhibitor | 0.065 0.008 CID_101164969 | CID_101164969 | |
| 0.086 | 0.069 | 0.086 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.056 | 0.039 | 0.056 | Carbonic anhydrase VB inhibitor | |||
| 0.077 | 0.061 | 0.077 | Carbonic anhydrase VI inhibitor | |||
| 0.091 | 0.076 | 0.091 | Anabolic | |||
| 0.028 | 0.013 | 0.028 | Acid ceramidase inhibitor | |||
| 0.065 | 0.05 | 0.065 | Potassium channel (ATP-sensitive) blocker | |||
| 0.044 | 0.03 | 0.044 | Geranyltranstransferase inhibitor | |||
| 0.06 | 0.046 | 0.06 | 5 Hydroxytryptamine 2A agonist | |||
| 0.024 | 0.011 | 0.024 | Imidazoline I1 receptor antagonist | |||
| 0.043 | 0.03 | 0.043 | Guanylate cyclase inhibitor | |||
| 0.058 | 0.045 | 0.058 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.08 | 0.067 | 0.08 | Alpha 2 adrenoreceptor antagonist | |||
| 0.119 | 0.106 | 0.119 | Diuretic | |||
| 0.148 | 0.136 | 0.336 | Insulin sensitizer | 0.336 0.01 CID_101164969 | CID_101164969 | |
| 0.101 | 0.089 | 0.101 | MAO inhibitor | |||
| 0.077 | 0.066 | 0.077 | Calcium antagonist | |||
| 0.02 | 0.008 | 0.02 | Adenosine A2a receptor agonist | |||
| 0.062 | 0.051 | 0.078 | Histone deacetylase inhibitor | 0.078 0.032 CID_101164969 | CID_101164969 | |
| 0.026 | 0.016 | 0.026 | Vanilloid 2 agonist | |||
| 0.099 | 0.089 | 0.099 | Cholesterol synthesis inhibitor | |||
| 0.051 | 0.041 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.046 | 0.036 | 0.046 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.042 | 0.033 | 0.05 | AICAR transformylase inhibitor | 0.05 0.022 CID_101164969 | CID_101164969 | |
| 0.06 | 0.05 | 0.06 | Histone deacetylase SIRT3 inhibitor | 0.06 0.05 CID_101164969 | ||
| 0.068 | 0.059 | 0.068 | Alpha 2a adrenoreceptor antagonist | |||
| 0.058 | 0.049 | 0.058 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.088 | 0.079 | 0.088 | Electrolyte absorption antagonist | |||
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | |||
| 0.042 | 0.034 | 0.042 | Dihydrofolate reductase inhibitor | |||
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | |||
| 0.039 | 0.032 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.074 | 0.067 | 0.074 | MAP kinase kinase 7 inhibitor | |||
| 0.084 | 0.077 | 0.084 | Glutamate release inhibitor | |||
| 0.185 | 0.179 | 0.185 | Cholesterol antagonist | |||
| 0.06 | 0.055 | 0.06 | Beta 3 adrenoreceptor antagonist | |||
| 0.063 | 0.057 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.087 | 0.082 | 0.087 | Gastric antisecretory | |||
| 0.014 | 0.009 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.031 | 0.027 | 0.031 | Fumarate hydratase inhibitor | |||
| 0.215 | 0.212 | 0.296 | Antibacterial | 0.296 0.138 CID_101164969 | CID_101164969 | |
| 0.05 | 0.047 | 0.05 | Argininosuccinate synthase inhibitor | |||
| 0.018 | 0.015 | 0.018 | Alpha 2b adrenoreceptor agonist | |||
| 0.078 | 0.075 | 0.078 | D-Ala-D-Ala ligase inhibitor | |||
| 0.046 | 0.043 | 0.046 | Squalene epoxidase inhibitor | |||
| 0.035 | 0.033 | 0.035 | Glutamate (mGluR8) agonist | |||
| 0.025 | 0.023 | 0.025 | 5 Hydroxytryptamine 1D agonist | |||
| 0.017 | 0.016 | 0.017 | Estrogen-related receptor gamma agonist | |||
| 0.023 | 0.022 | 0.023 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.031 | 0.03 | 0.031 | Phosphoglycerate kinase inhibitor | |||
| 0.038 | 0.037 | 0.038 | NMDA receptor subunit 3B antagonist | |||
| 0.069 | 0.068 | 0.069 | Vanilloid 4 agonist | |||
| 0.036 | 0.036 | 0.052 | Oxytocin agonist | 0.052 0.022 CID_101164969 | CID_101164969 | |
| 0.06 | 0.063 | 0.384 | Histidine decarboxylase inhibitor | 0.384 0.004 CID_101164969 | CID_101164969 | |
| 0.057 | 0.06 | 0.087 | Protease 3C (Human rhinovirus) inhibitor | 0.087 0.022 CID_101164969 | CID_101164969 | |
| 0.03 | 0.038 | 0.06 | Carbonic anhydrase I stimulant | 0.06 0.012 CID_101164969 | CID_101164969 | |
| 0.116 | 0.126 | 0.267 | Thiol protease inhibitor | 0.267 0.023 CID_101164969 | CID_101164969 | |
| 0.04 | 0.051 | 0.103 | Ornithine carbamoyltransferase inhibitor | 0.103 0.015 CID_101164969 | CID_101164969 | |
| 0.019 | 0.032 | 0.047 | Lysine carboxypeptidase inhibitor | 0.047 0.008 CID_101164969 | CID_101164969 | |
| 0.04 | 0.057 | 0.071 | Bombesin 2 receptor antagonist | 0.071 0.019 CID_101164969 | CID_101164969 | |
| 0.039 | 0.057 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.043 CID_101164969 | CID_101164969 | |
| 0.009 | 0.032 | 0.046 | Aminopeptidase A inhibitor | 0.046 0.004 CID_101164969 | CID_101164969 | |
| 0.02 | 0.044 | 0.038 | Peptide deformylase inhibitor | 0.038 0.015 CID_101164969 | CID_101164969 | |
| 0.025 | 0.055 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.018 CID_101164969 | CID_101164969 | |
| 0.02 | 0.051 | 0.034 | Calcitonin receptor agonist | 0.034 0.023 CID_101164969 | CID_101164969 | |
| 0.016 | 0.052 | 0.072 | Arginase inhibitor | 0.072 0.007 CID_101164969 | CID_101164969 | |
| 0.089 | 0.126 | 0.238 | Toll-Like receptor 2 antagonist | 0.238 0.011 CID_101164969 | CID_101164969 | |
| 0.048 | 0.085 | 0.27 | Catalase inhibitor | 0.27 0.007 CID_101164969 | CID_101164969 | |
| 0.07 | 0.11 | 0.082 | Vanilloid agonist | 0.082 0.064 CID_101164969 | CID_101164969 | |
| 0.076 | 0.116 | 0.366 | Chelator | 0.366 0.007 CID_101164969 | CID_101164969 | |
| 0.182 | 0.222 | 0.366 | Interleukin 2 agonist | 0.366 0.039 CID_101164969 | CID_101164969 | |
| 0.102 | 0.143 | 0.232 | Phospholipase A2 inhibitor | 0.232 0.028 CID_101164969 | CID_101164969 | |
| 0.027 | 0.069 | 0.036 | AMPA 4 receptor antagonist | 0.036 0.034 CID_101164969 | CID_101164969 | |
| 0.035 | 0.077 | 0.063 | Cathepsin L inhibitor | 0.063 0.035 CID_101164969 | CID_101164969 | |
| 0.066 | 0.109 | 0.106 | Alcohol dehydrogenase inhibitor | 0.106 0.046 CID_101164969 | CID_101164969 | |
| 0.022 | 0.066 | 0.22 | Toll-Like receptor 2 agonist | 0.22 0.006 CID_101164969 | CID_101164969 | |
| 0.024 | 0.072 | 0.332 | Glycine transporter 2 inhibitor | 0.332 0.003 CID_101164969 | CID_101164969 | |
| 0.025 | 0.077 | 0.103 | Ribonucleoside-diphosphate reductase inhibitor | 0.103 0.019 CID_101164969 | CID_101164969 | |
| 0.012 | 0.066 | 0.016 | Tryptophan hydroxylase 1 inhibitor | 0.016 0.015 CID_101164969 | CID_101164969 | |
| 0.024 | 0.079 | 0.102 | Ribonucleotide reductase inhibitor | 0.102 0.02 CID_101164969 | CID_101164969 | |
| 0.024 | 0.081 | 0.047 | Antimetabolite | 0.047 0.033 CID_101164969 | CID_101164969 | |
| 0.036 | 0.096 | 0.063 | CD45 antagonist | 0.063 0.019 CID_101164969 | CID_101164969 | |
| 0.02 | 0.08 | 0.042 | Factor XIIIa inhibitor | 0.042 0.021 CID_101164969 | CID_101164969 | |
| 0.025 | 0.087 | 0.074 | Metalloproteinase-3 inhibitor | 0.074 0.018 CID_101164969 | CID_101164969 | |
| 0.041 | 0.104 | 0.075 | NMDA receptor agonist | 0.075 0.032 CID_101164969 | CID_101164969 | |
| 0.072 | 0.136 | 0.179 | Mucolytic | 0.179 0.019 CID_101164969 | CID_101164969 | |
| 0.023 | 0.093 | 0.042 | Thymidylate synthase inhibitor | 0.042 0.038 CID_101164969 | CID_101164969 | |
| 0.057 | 0.131 | 0.296 | Glutathione S-transferase inhibitor | 0.296 0.003 CID_101164969 | CID_101164969 | |
| 0.068 | 0.142 | 0.182 | Proteasome inhibitor | 0.182 0.031 CID_101164969 | CID_101164969 | |
| 0.051 | 0.126 | 0.138 | Monophenol monooxygenase inhibitor | 0.138 0.052 CID_101164969 | CID_101164969 | |
| 0.013 | 0.089 | 0.068 | Complement C3a chemotactic receptor antagonist | 0.068 0.018 CID_101164969 | CID_101164969 | |
| 0.169 | 0.247 | 0.309 | Histamine release inhibitor | 0.309 0.119 CID_101164969 | CID_101164969 | |
| 0.023 | 0.107 | 0.047 | Neurokinin 2 agonist | 0.047 0.022 CID_101164969 | CID_101164969 | |
| 0.026 | 0.113 | 0.148 | Neutrophil collagenase inhibitor | 0.148 0.013 CID_101164969 | CID_101164969 | |
| 0.013 | 0.102 | 0.034 | Calcium-sensing receptor agonist | 0.034 0.01 CID_101164969 | CID_101164969 | |
| 0.037 | 0.138 | 0.111 | Sirtuin 1 inhibitor | 0.111 0.018 CID_101164969 | CID_101164969 | |
| 0.026 | 0.13 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.061 0.032 CID_101164969 | CID_101164969 | |
| 0.095 | 0.207 | 0.298 | DNA methylase inhibitor | 0.298 0.028 CID_101164969 | CID_101164969 | |
| 0.041 | 0.157 | 0.097 | Somatostatin 1 agonist | 0.097 0.036 CID_101164969 | CID_101164969 | |
| 0.049 | 0.172 | 0.155 | Expectorant | 0.155 0.033 CID_101164969 | CID_101164969 | |
| 0.016 | 0.142 | 0.047 | Matrix metalloproteinase 1 inhibitor | 0.047 0.04 CID_101164969 | CID_101164969 | |
| 0.006 | 0.134 | 0.026 | Aminopeptidase P inhibitor | 0.026 0.013 CID_101164969 | CID_101164969 | |
| 0.033 | 0.166 | 0.054 | DNA helicase inhibitor | 0.054 0.038 CID_101164969 | CID_101164969 | |
| 0.084 | 0.219 | 0.252 | DNA methyltransferase I inhibitor | 0.252 0.046 CID_101164969 | CID_101164969 | |
| 0.036 | 0.18 | 0.083 | Metalloproteinase-9 inhibitor | 0.083 0.042 CID_101164969 | CID_101164969 | |
| 0.025 | 0.169 | 0.11 | Matrix metalloproteinase inhibitor | 0.11 0.023 CID_101164969 | CID_101164969 | |
| 0.132 | 0.281 | 0.226 | Antithrombotic | 0.226 0.148 CID_101164969 | CID_101164969 | |
| 0.033 | 0.184 | 0.1 | Metalloproteinase-2 inhibitor | 0.1 0.038 CID_101164969 | CID_101164969 | |
| 0.022 | 0.197 | 0.051 | Cathepsin D inhibitor | 0.051 0.041 CID_101164969 | CID_101164969 | |
| 0.026 | 0.206 | 0.068 | Bombesin 1 receptor agonist | 0.068 0.033 CID_101164969 | CID_101164969 | |
| 0.019 | 0.204 | 0.049 | Bombesin antagonist | 0.049 0.031 CID_101164969 | CID_101164969 | |
| 0.014 | 0.201 | 0.073 | Aminopeptidase N inhibitor | 0.073 0.019 CID_101164969 | CID_101164969 | |
| 0.075 | 0.266 | 0.343 | Growth hormone agonist | 0.343 0.024 CID_101164969 | CID_101164969 | |
| 0.02 | 0.212 | 0.095 | Aminopeptidase microsomal inhibitor | 0.095 0.019 CID_101164969 | CID_101164969 | |
| 0.046 | 0.252 | 0.111 | Caspase 3 inhibitor | 0.111 0.074 CID_101164969 | CID_101164969 | |
| 0.063 | 0.279 | 0.148 | Factor V inhibitor | 0.148 0.019 CID_101164969 | CID_101164969 | |
| 0.013 | 0.231 | 0.046 | Growth hormone release inhibitor | 0.046 0.025 CID_101164969 | CID_101164969 | |
| 0.056 | 0.28 | 0.234 | Histone deacetylase SIRT1 inhibitor | 0.234 0.021 CID_101164969 | CID_101164969 | |
| 0.018 | 0.243 | 0.051 | Neurotensin receptor antagonist | 0.051 0.028 CID_101164969 | CID_101164969 | |
| 0.019 | 0.265 | 0.048 | Cathepsin F inhibitor | 0.048 0.016 CID_101164969 | CID_101164969 | |
| 0.003 | 0.25 | 0.027 | Neutral endopeptidase inhibitor | 0.027 0.012 CID_101164969 | CID_101164969 | |
| 0.011 | 0.267 | 0.058 | Endothelin-converting enzyme inhibitor | 0.058 0.026 CID_101164969 | CID_101164969 | |
| 0.023 | 0.283 | 0.069 | Carbonic anhydrase II stimulant | 0.069 0.015 CID_101164969 | CID_101164969 | |
| 0.002 | 0.275 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.014 0.01 CID_101164969 | CID_101164969 | |
| 0.013 | 0.319 | 0.046 | Cholecystokinin B agonist | 0.046 0.018 CID_101164969 | CID_101164969 | |
| 0.011 | 0.33 | 0.062 | Erythropoietin receptor agonist | 0.062 0.017 CID_101164969 | CID_101164969 | |
| 0.026 | 0.35 | 0.058 | Cathepsin E inhibitor | 0.058 0.044 CID_101164969 | CID_101164969 | |
| 0.018 | 0.359 | 0.068 | Cathepsin B inhibitor | 0.068 0.03 CID_101164969 | CID_101164969 | |
| 0.013 | 0.361 | 0.083 | Angiotensin-converting enzyme inhibitor | 0.083 0.012 CID_101164969 | CID_101164969 | |
| 0.014 | 0.37 | 0.048 | Neuropeptide agonist | 0.048 0.043 CID_101164969 | CID_101164969 | |
| 0.015 | 0.379 | 0.046 | Glutamate (mGluR8) antagonist | 0.046 0.011 CID_101164969 | CID_101164969 | |
| 0.025 | 0.39 | 0.16 | Histone deacetylase class III inhibitor | 0.16 0.037 CID_101164969 | CID_101164969 | |
| 0.004 | 0.37 | 0.132 | Leukotriene A4 hydrolase inhibitor | 0.132 0.005 CID_101164969 | CID_101164969 | |
| 0.016 | 0.386 | 0.068 | Thrombin inhibitor | 0.068 0.058 CID_101164969 | CID_101164969 | |
| 0.006 | 0.382 | 0.053 | Collagenase inhibitor | 0.053 0.027 CID_101164969 | CID_101164969 | |
| 0.005 | 0.4 | 0.032 | Bradykinin B2 receptor agonist | 0.032 0.017 CID_101164969 | CID_101164969 | |
| 0.044 | 0.488 | 0.148 | Folate antagonist | 0.148 0.023 CID_101164969 | CID_101164969 | |
| 0.006 | 0.477 | 0.042 | Macrophage elastase inhibitor | 0.042 0.031 CID_101164969 | CID_101164969 | |
| 0.062 | 0.556 | 0.414 | Sodium/bile acid cotransporter inhibitor | 0.414 0.013 CID_101164969 | CID_101164969 | |
| 0.082 | 0.587 | 0.275 | Peptidyltransferase inhibitor | 0.275 0.035 CID_101164969 | CID_101164969 | |
| 0.006 | 0.515 | 0.046 | Integrin alpha5beta1 antagonist | 0.046 0.021 CID_101164969 | CID_101164969 | |
| 0.015 | 0.527 | 0.132 | Protease inhibitor | 0.132 0.039 CID_101164969 | CID_101164969 | |
| 0.019 | 0.546 | 0.078 | Chymotrypsin inhibitor | 0.078 0.056 CID_101164969 | CID_101164969 | |
| 0.022 | 0.558 | 0.062 | Caspase 9 inhibitor | 0.062 0.043 CID_101164969 | CID_101164969 | |
| 0.01 | 0.564 | 0.081 | Nitric oxide donor | 0.081 0.022 CID_101164969 | CID_101164969 | |
| 0.003 | 0.562 | 0.063 | GP IIb/IIIa receptor antagonist | 0.063 0.027 CID_101164969 | CID_101164969 | |
| 0.008 | 0.59 | 0.038 | VCAM antagonist | 0.038 0.031 CID_101164969 | CID_101164969 | |
| 0.008 | 0.59 | 0.039 | VCAM-1 antagonist | 0.039 0.031 CID_101164969 | CID_101164969 | |
| 0.015 | 0.649 | 0.406 | Angiogenesis stimulant | 0.406 0.021 CID_101164969 | CID_101164969 | |
| 0.005 | 0.651 | 0.096 | Selectin antagonist | 0.096 0.029 CID_101164969 | CID_101164969 | |
| 0.033 | 0.681 | 0.226 | Hypoglycemic | 0.226 0.092 CID_101164969 | CID_101164969 | |
| 0.004 | 0.668 | 0.039 | Integrin antagonist | 0.039 0.031 CID_101164969 | CID_101164969 | |
| 0.004 | 0.67 | 0.033 | Kinesin antagonist | 0.033 0.032 CID_101164969 | CID_101164969 | |
| 0.004 | 0.67 | 0.033 | Kinesin-like protein 1 inhibitor | 0.033 0.032 CID_101164969 | CID_101164969 | |
| 0.018 | 0.686 | 0.111 | Nav1.4 sodium channel blocker | 0.111 0.062 CID_101164969 | CID_101164969 | |
| 0.005 | 0.681 | 0.095 | Glucagon-like peptide 1 agonist | 0.095 0.025 CID_101164969 | CID_101164969 | |
| 0.013 | 0.693 | 0.121 | Bone formation stimulant | 0.121 0.085 CID_101164969 | CID_101164969 | |
| 0.008 | 0.7 | 0.112 | Lipid peroxidase inhibitor | 0.112 0.102 CID_101164969 | CID_101164969 | |
| 0.004 | 0.696 | 0.035 | Protocollagen prolyl hydroxylase inhibitor | 0.035 0.01 CID_101164969 | CID_101164969 | |
| 0.015 | 0.713 | 0.12 | Insulin secretagoues | 0.12 0.111 CID_101164969 | CID_101164969 | |
| 0.025 | 0.73 | 0.257 | Hematopoietic | 0.257 0.006 CID_101164969 | CID_101164969 | |
| 0.027 | 0.738 | 0.305 | Hepatoprotectant | 0.305 0.028 CID_101164969 | CID_101164969 | |
| 0.023 | 0.781 | 0.107 | Transcription factor NF kappa B stimulant | 0.107 0.033 CID_101164969 | CID_101164969 | |
| 0.015 | 0.781 | 0.08 | Adenine nucleotide translocase inhibitor | 0.08 0.009 CID_101164969 | CID_101164969 | |
| 0.009 | 0.794 | 0.101 | Factor XII inhibitor | 0.101 0.037 CID_101164969 | CID_101164969 | |
| 0.013 | 0.844 | 0.279 | Cyclophilin D inhibitor | 0.279 0.182 CID_101164969 | CID_101164969 | |
| 0.005 | 0.85 | 0.099 | Aminoacyl-tRNA synthetase inhibitor | 0.099 0.046 CID_101164969 | CID_101164969 | |
| 0.009 | 0.906 | 0.27 | Immunomodulator | 0.27 0.1 CID_101164969 | CID_101164969 | |
| 0.005 | 0.93 | 0.312 | Thrombolytic | 0.312 0.022 CID_101164969 | CID_101164969 | |
| 0.005 | 0.949 | 0.417 | Interleukin antagonist | 0.417 0.028 CID_101164969 | CID_101164969 | |
| 0.004 | 0.967 | 0.263 | Platelet antagonist | 0.263 0.067 CID_101164969 | CID_101164969 | |
| 0.004 | 0.976 | 0.193 | Anticoagulant | 0.193 0.056 CID_101164969 | CID_101164969 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |